CLASS II ONGOING Device recall · Reported 25 Mar 2026 · FDA Enforcement Report
Artegraft Vascular Graft recalled by LeMaitre Vascular
LeMaitre Vascular is recalling Artegraft Vascular Graft, distributed nationwide in the US. The recall was initiated on 10 Feb 2026 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1574-2026
- FDA event ID
- 98409
- Recalling firm
- LeMaitre Vascular, North Brunswick, NJ
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 10 Feb 2026
- FDA classified
- 19 Mar 2026
- Reported
- 25 Mar 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
- Device type
- Heart & Vascular Devices
Timeline
| 10 Feb 2026 | Recall initiated by company | |
| 19 Mar 2026 | Classified by FDA | +37 days |
| 25 Mar 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling mix-up resulting in the incorrect lot outer packaging of product.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Artegraft Vascular Graft; REF#: AG740;
Where it was distributed
US Nationwide distribution in the state of IL.
Questions about this recall
Why was it recalled?
Labeling mix-up resulting in the incorrect lot outer packaging of product.
Which lots are affected?
REF#: AG740; UDI-DI: 00316837000299; Serial Number: 24GG298-022; Expiration Date: 28Jun2027;
Where was it sold?
US Nationwide distribution in the state of IL.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from LeMaitre Vascular
All 71| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | TufTex¿ Over-the-Wire Embolectomy Catheter recalled | LeMaitre Vascular | Other | Nationwide |
| Device | CLASS II | Artegraft¿ Collagen Vascular Graft recalled by LeMaitre Vascular | LeMaitre Vascular | Packaging Defects | AR |
| Device | CLASS II | Artegraft Collagen Vascular Graft recalled by LeMaitre Vascular | LeMaitre Vascular | Labeling Errors | NJ |
| Device | CLASS II | Artegraft Collagen Vascular Grafts recalled by LeMaitre Vascular | LeMaitre Vascular | Other | Nationwide |
| Device | CLASS II | Pruitt Irrigation Occlusion Catheter recalled by LeMaitre Vascular | LeMaitre Vascular | Sterility | Nationwide |
Other Heart & Vascular Devices recalls
All 6,271| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | Cardinal Health Presource PBDS kits recalled | Cardinal Health 200 | Other | IL |
| Device | CLASS I | Impella Connect Optical AIC, Packaged recalled by Abiomed | Abiomed | Potency & Assay | Nationwide |
| Device | CLASS I | Impella Optical Controller, Packaged recalled by Abiomed | Abiomed | Potency & Assay | Nationwide |
| Device | CLASS I | Automated Impella Controller, Packaged recalled by Abiomed | Abiomed | Potency & Assay | Nationwide |
| Device | CLASS II | Direxion Torqueable Microcatheter, Ngmc/Fathom/027/Straight/1RO/130 recalled | Boston Scientific Cork | Device Malfunction | Nationwide |